
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 6.89 | 6.89 | 0.00 |
Shares | 89.57 | 89.57 | 0.00 |
Other | 3.54 | 3.54 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 33.08 | 22.09 |
Price to Book | 3.76 | 3.14 |
Price to Sales | 3.14 | 2.11 |
Price to Cash Flow | 19.19 | 12.37 |
Dividend Yield | 0.14 | 0.65 |
5 Years Earnings Growth | 11.15 | 14.19 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 38.43 | 20.24 |
Industrials | 28.74 | 20.32 |
Technology | 20.83 | 23.94 |
Financial Services | 4.57 | 10.12 |
Consumer Cyclical | 4.11 | 11.09 |
Utilities | 3.32 | 1.45 |
Number of long holdings: 51
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
RBC Bearings | US75524B1044 | 6.17 | 397.03 | +1.91% | |
Natera Inc | US6323071042 | 4.57 | 143.38 | -3.38% | |
Guidewire | US40171V1008 | 4.17 | 221.15 | +0.47% | |
BioLife Solutions | US09062W2044 | 3.96 | 21.42 | +1.81% | |
Impulse Dynamics Ireland Series F-3 | - | 3.54 | - | - | |
GeneDx Holdings Corp Ordinary Shares - Class A | - | 3.08 | - | - | |
Vertex | US92538J1060 | 3.06 | 35.45 | 0.00% | |
Repligen | US7599161095 | 2.91 | 124.04 | +3.58% | |
Q2 Holdings | US74736L1098 | 2.79 | 91.44 | +1.14% | |
FTAI Aviation | KYG3730V1059 | 2.52 | 115.65 | +0.43% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Alger Spectra Z | 2.14B | 13.18 | 31.05 | 15.05 | ||
Alger Capital Appreciation Focus Fz | 2.09B | 16.99 | 35.13 | 18.27 | ||
Alger Spectra A | 1.47B | 12.97 | 30.61 | 14.68 | ||
Alger Capital Appreciation Instl I | 1.15B | 13.35 | 32.47 | 16.01 | ||
Alger Capital Appreciation A | 1.09B | 13.21 | 32.48 | 15.98 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review